secwatch.observer — SEC 8-K summary
======================================

Issuer:     CalciMedica, Inc. (CALC)
CIK:        0001534133
Form:       8-K
Filed at:   2024-01-22T23:59:59+00:00
Accession:  0001193125-24-011738
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.02, 3.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CalciMedica raises up to $55M in private placement; $20.4M upfront from new and existing investors
--------------------------------------------------------------------------------

- Upfront gross proceeds $20.4M from sale of 5.1M shares and pre-funded warrants to purchase 351,352 shares at $3.70/share.
- Additional up to ~$34.2M possible if Tranche A ($5.36/share) and Tranche B ($7.15/share) warrants are exercised in cash.
- Tranche A warrants expire earlier of 30 days after topline AP data or Dec 31, 2024; Tranche B earlier of 30 days after AKI data or Dec 31, 2026.
- Cash, equivalents and short-term investments were $11.2M as of Dec 31, 2023 (preliminary); proceeds expected to fund Phase 2 trials in AP and AKI.
- New investors include Deerfield Management, Soleus Capital, Stonepine Capital, Aisling Capital; JonesTrading as placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534133/000119312524011738/0001193125-24-011738-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534133/000119312524011738/d738337d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-011738

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer